Fujitsu Small Research Lab program strengthens industry-academia collaboration with growing global R&D network
TOKYO, Mar 17, 2023 – (JCN Newswire) – Fujitsu today revealed its progress over the…
Month: March 2023
Fujitsu and Ochanomizu University establish new AI ethics research lab, leveraging AI technologies to promote gender equality
TOKYO, Mar 17, 2023 – (JCN Newswire) – Fujitsu and Ochanomizu University today announced the…
Rocket Lab Successfully Launches 34th Electron Rocket, Second Mission from Virginia
LONG BEACH, Calif.–(BUSINESS WIRE)–$RKLB–Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a…
Long-Term Data from CANbridge Pharmaceuticals CAN008 Phase 1/2 Trial in Glioblastoma Multiforme Shows 67% Five-Year Overall Survival Rate Compared to 8.2% in Institutional Database
Data to be Presented at the ESMO Sarcoma and Rare Cancers Annual Congress 83% overall…
Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma, the most common pediatric brain cancer
New approval based on TADPOLE trial showing overall response rate (ORR) of 47% and median…
Curia Appoints Philip Macnabb as Chief Executive Officer
Philip Macnabb Philip Macnabb appointed CEO of Curia ALBANY, N.Y., March 16, 2023 (GLOBE NEWSWIRE)…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Allbirds, Inc. (BIRD) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
crypto.ro Announces ‘The Alliance’, the Most Anticipated Crypto Conference in 2023
TIMISOARA, Romania, Mar 17, 2023 – (ACN Newswire) – Crypto.ro, Romania’s leading cryptocurrency and blockchain…
SmartStop Self Storage Wins Reputation’s 800 Award for Second Consecutive Year
LADERA RANCH, Calif.–(BUSINESS WIRE)–SmartStop Self Storage REIT, Inc. (“SmartStop” or the “Company”), a self-managed and…
Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023
HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced…
Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023
HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced…
Jounce Therapeutics Announces Results from Pre-Planned Data Review of INNATE Phase 2 Trial of JTX-8064 and Pimivalimab Demonstrating Deep and Durable Responses in Platinum Resistant Ovarian Cancer
Ovarian Combination Cohort Target Lesion % Change from Baseline over Time Ovarian Combination Cohort Target…
Jounce Therapeutics Announces Results from Pre-Planned Data Review of INNATE Phase 2 Trial of JTX-8064 and Pimivalimab Demonstrating Deep and Durable Responses in Platinum Resistant Ovarian Cancer
Ovarian Combination Cohort Target Lesion % Change from Baseline over Time Ovarian Combination Cohort Target…
Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp
Significant value unlocked for Enzo shareholders with continued focus on remaining businesses. FARMINGDALE, NY, March…
Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp
Significant value unlocked for Enzo shareholders with continued focus on remaining businesses. FARMINGDALE, NY, March…
Lifecore Biomedical Signs Term Sheet with Existing Long-Term Customer to Expand CDMO Relationship
Provides $10 million upfront cash commitment to Lifecore for infrastructure preparation and production capacity preparation…
Lifecore Biomedical Signs Term Sheet with Existing Long-Term Customer to Expand CDMO Relationship
Provides $10 million upfront cash commitment to Lifecore for infrastructure preparation and production capacity preparation…
Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET SAN…
Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET SAN…
Lifecore Biomedical Announces Intent to Explore Strategic Alternatives
CHASKA, Minn., March 16, 2023 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (“Lifecore” or the “Company”),…